Patent No. EP4335929 (titled "Non-Invasive Determination Of Methylome Of Tumor From Plasma") was filed by The Chinese University OF Hong Kong on Sep 20, 2013. The application was issued on Jan 21, 2026.
Plasma DNA methylation test that detects fetal or tumor DNA in maternal blood to avoid invasive procedures. The method sequences cell-free DNA and identifies specific methylation patterns to separate fetal or cancer DNA from the mother's background. It also checks for gene deletions or amplifications to confirm cancer presence. This approach allows non-invasive screening, monitoring, and prognosis without needing tissue biopsies.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description